NIKKEI 225
38,490.17 -347.29 (-0.89%) HANG SENG
18,424.96 -19.15 (-0.10%) CRUDE OIL
74.11 +0.86 (+1.17%) GOLD FUTURES
2,375.70 +28.30 (+1.21%) DOW
38,781.92 +70.63 (+0.18%) Bitcoin GBP
55,481.36 +281.30 (+0.51%)
AIM ImmunoTech Inc. (AIM)
| Previous close | 0.3800 |
| Open | 0.3724 |
| Bid | 0.3750 x 1400 |
| Ask | 0.3980 x 900 |
| Day's range | 0.3511 - 0.4000 |
| 52-week range | 0.3100 - 0.7500 |
| Volume | |
| Avg. volume | 253,222 |
| Market cap | 20.405M |
| Beta (5Y monthly) | -0.11 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.6400 |
| Earnings date | 13 Aug 2024 - 19 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.58 |
GlobeNewswireAIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series
Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Wednesday, June 5th at 12:00 PM ETOCALA, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series on Wednesday, June 5, 2024 at 12:00 PM ET. As part of the event, Mr. Equels will provide a corporate overview and business outlook. I
- GlobeNewswire
AIM ImmunoTech Announces Pricing of $2.0 Million Registered Direct Offering
OCALA, Fla., May 31, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 5,640,958 shares of common stock in a registered direct offering at a purchase price of $0.363 per share. In a concurrent private placement, the Company also agreed to issue unregistered Class A warrants to purchase up to an aggregate of 5,640,958 shares of common s
- GlobeNewswire
AIM ImmunoTech to Participate in Two Upcoming Investor Conferences
OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that AIM Chief Executive Officer Thomas K. Equels will participate in two upcoming investor conferences. Details for the presentations are as follows: Event: Healthcare Company Showcase hosted by Alliance Global PartnersDate and Time: Tuesday, May 21, 2024, at 3:20 PM ETWebcast Link Event: LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarDate and T
